AU3162001A - Medicament, a method for its production and the use thereof - Google Patents
Medicament, a method for its production and the use thereofInfo
- Publication number
- AU3162001A AU3162001A AU31620/01A AU3162001A AU3162001A AU 3162001 A AU3162001 A AU 3162001A AU 31620/01 A AU31620/01 A AU 31620/01A AU 3162001 A AU3162001 A AU 3162001A AU 3162001 A AU3162001 A AU 3162001A
- Authority
- AU
- Australia
- Prior art keywords
- medicament
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19961834 | 1999-12-21 | ||
DE19961834 | 1999-12-21 | ||
PCT/EP2000/013036 WO2001045678A2 (en) | 1999-12-21 | 2000-12-20 | Medicament, a method for its production and the use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3162001A true AU3162001A (en) | 2001-07-03 |
Family
ID=7933684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31620/01A Abandoned AU3162001A (en) | 1999-12-21 | 2000-12-20 | Medicament, a method for its production and the use thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3162001A (en) |
WO (1) | WO2001045678A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0105944D0 (en) * | 2001-03-10 | 2001-04-25 | Royal Devon & Exeter Healthcar | Anaesthetic Formulation |
ES2214126B1 (en) * | 2003-01-20 | 2006-02-16 | Montserrat Torne Cabanes | NEW FORMULATION FOR TOPICAL ANESTHESIA, ITS CORRESPONDING KIT MONODOSIS AND ITS APPLICATIONS IN SURGERY. |
DE10303669A1 (en) * | 2003-01-28 | 2004-07-29 | Hans-Knöll-Institut für Naturstoff-Forschung e.V. | New quaternary ammonioalkyl carbonate esters useful for treating bacterial and fungal infections and potentially useful for regulating cholesterol biosynthesis |
WO2007043641A1 (en) | 2005-10-14 | 2007-04-19 | Fukuoka University | Inhibitor of transplanted islet dysfunction in islet transplantation |
RU2450830C2 (en) | 2005-10-21 | 2012-05-20 | Чугаи Сейяку Кабусики Кайся | Agent for cardiopathy |
AR057582A1 (en) | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | AGENTS TO DELETE INDUCTION OF CYTOTOXIC T LYMPHOCYTES |
WO2007086490A1 (en) | 2006-01-27 | 2007-08-02 | Keio University | Remedy for disease associated with choroidal angiogenesis |
EP2025346B1 (en) * | 2006-04-07 | 2016-08-10 | Osaka University | Muscle regeneration promoter |
EP2425858A3 (en) | 2006-11-20 | 2012-03-28 | President and Fellows of Harvard College | Compositions for treating pain and pruritus |
MX2009007830A (en) | 2007-01-23 | 2009-10-07 | Univ Shinshu | Chronic rejection inhibitor. |
JP5276020B2 (en) * | 2007-02-13 | 2013-08-28 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | Cationic estradiol derivative, synthesis method thereof, and pharmaceutical composition |
TWI528973B (en) | 2008-06-05 | 2016-04-11 | Chugai Pharmaceutical Co Ltd | Nerve infiltration inhibitor |
CN102725401A (en) | 2009-07-10 | 2012-10-10 | 哈佛大学校长及研究员协会 | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
WO2011149051A1 (en) | 2010-05-28 | 2011-12-01 | 中外製薬株式会社 | Antitumor t cell response enhancer |
CN105315170B (en) * | 2014-08-01 | 2017-08-25 | 四川大学华西医院 | Dimethyl benzene ammonium long-chain compound, preparation, self-assembly structure and application |
EP3331609A4 (en) | 2015-08-03 | 2019-03-27 | President and Fellows of Harvard College | Charged ion channel blockers and methods for use |
JP7185884B2 (en) | 2017-05-02 | 2022-12-08 | 国立研究開発法人国立精神・神経医療研究センター | METHOD FOR PREDICTING AND DETERMINING THERAPEUTIC EFFECT OF IL-6 AND NEUTROPHIL-RELATED DISEASE |
EP3698808A4 (en) | 2017-10-20 | 2021-07-14 | Hyogo College Of Medicine | Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion |
CN109574866B (en) * | 2019-01-15 | 2022-07-15 | 中国科学院成都有机化学有限公司 | Preparation method of 2, 6-dimethylaniline long-chain compound |
MA55311A (en) | 2019-03-11 | 2022-01-19 | Nocion Therapeutics Inc | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
EP3937934A4 (en) | 2019-03-11 | 2022-11-09 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
CA3129131A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
BR112022008575A2 (en) | 2019-11-06 | 2022-08-09 | Nocion Therapeutics Inc | LOADED ION CHANNEL BLOCKERS AND METHODS FOR USE |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
AU2021236130A1 (en) | 2020-03-11 | 2022-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1279214A (en) * | 1970-01-22 | 1972-06-28 | Forest Laboratories | Long-acting oral carrier |
US3821375A (en) * | 1970-11-05 | 1974-06-28 | Alper C | Treatment of otitis of dogs and cats with chloramphenicol-squalane composition |
JPS5576814A (en) * | 1978-12-06 | 1980-06-10 | Green Cross Corp:The | Preservative solution for organ transplant |
IE51145B1 (en) * | 1980-03-07 | 1986-10-15 | Efamol Ltd | Pharmaceutical and dietary compositions |
US4446140A (en) * | 1981-12-10 | 1984-05-01 | Nelson Research & Development Company | Method and composition for treating mouth pain |
JPH0816055B2 (en) * | 1987-08-21 | 1996-02-21 | 味の素株式会社 | Oral patch |
RU1824187C (en) * | 1990-04-09 | 1993-06-30 | Харьковский Медицинский Институт | Method of treating myasthenia |
CN1092987A (en) * | 1993-04-02 | 1994-10-05 | 中国人民解放军81378部队医院 | Anti-inflammation, mixed liquid for vertebral canal |
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
CN1114190A (en) * | 1994-06-07 | 1996-01-03 | 周波 | Mixed treating liquid of high molecular synthetic material for double-fold eyelid operation |
JPH08245369A (en) * | 1995-03-08 | 1996-09-24 | Tendou Seiyaku Kk | Mucosa-protecting agent |
DE19715594A1 (en) * | 1997-04-15 | 1998-10-22 | Bayer Ag | Analgesic combination |
CN1185975A (en) * | 1997-07-31 | 1998-07-01 | 占汝兴 | Medicinal liquid for acne |
-
2000
- 2000-12-20 AU AU31620/01A patent/AU3162001A/en not_active Abandoned
- 2000-12-20 WO PCT/EP2000/013036 patent/WO2001045678A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001045678A3 (en) | 2002-04-11 |
WO2001045678A2 (en) | 2001-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3162001A (en) | Medicament, a method for its production and the use thereof | |
AU2001262318A1 (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
AU1271201A (en) | Azepinoindole derivatives, the production and use thereof | |
AU6231801A (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
AU2002213977A1 (en) | Novel anticholinergics, method for the production thereof and use thereof as medicaments | |
ZA200104196B (en) | Azepinoindole derivatives, the production and use thereof. | |
AU2856499A (en) | Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same | |
ZA200202521B (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds. | |
AU3156600A (en) | Novel epothilon derivatives, method for the production thereof and their pharmaceutical application | |
IL144370A0 (en) | Epothilon derivatives, method for the production and the use thereof as pharmaceuticals | |
AU2298200A (en) | Stabilized filler, its production and use | |
AU5208200A (en) | Screwed connection, fastener for said connection and method for the production thereof | |
AU2001260110A1 (en) | Novel LHRH-antagonists, Production and Use Thereof as Medicament | |
AU3825700A (en) | Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines | |
AU2001262229A1 (en) | Cyclipostins, a method for their production and the use of the same | |
AU2002227966A1 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof | |
ZA200103191B (en) | Vancoresmycin, a process for its production and its use as a pharmaceutical. | |
AU2001289844A1 (en) | Amifostine-monohydrate and a method for the production thereof | |
HUP0102370A3 (en) | Mumbaistatin, a process for its production and its use as a pharmaceutical | |
AU2002348998A1 (en) | N-methyl-homocystines, use thereof and method for the production thereof | |
AU7517800A (en) | 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments | |
AU1021001A (en) | Cyclic biphenyls, method for the production thereof, and their use as medicaments | |
AU5286499A (en) | Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments | |
AU2401401A (en) | Migrastatin, process for producing the same and medicinal compositions | |
AU4776599A (en) | Coccidiosis vaccine, method for the production thereof, and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |